These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2915763)

  • 1. L-carnitine addition to dialysis fluid. A therapeutic alternative for hemodialysis patients.
    Vacha GM; Giorcelli G; d'Iddio S; Valentini G; Bagiella E; Procopio A; di Donato S; Ashbrook D; Corsi M
    Nephron; 1989; 51(2):237-42. PubMed ID: 2915763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dialysate composition on the lipid response to L-carnitine supplementation.
    Zilleruelo G; Novak M; Hsia SL; Goldberg R; Abitbol C; Monkus E; Strauss J
    Kidney Int Suppl; 1989 Nov; 27():S259-63. PubMed ID: 2699997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients.
    Elisaf M; Bairaktari E; Katopodis K; Pappas M; Sferopoulos G; Tzallas C; Tsolas O; Siamopoulos KC
    Am J Nephrol; 1998; 18(5):416-21. PubMed ID: 9730566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
    Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of L-carnitine on the serum lipoproteins and HDL-C subclasses in hemodialysis patients.
    Argani H; Rahbaninoubar M; Ghorbanihagjo A; Golmohammadi Z; Rashtchizadeh N
    Nephron Clin Pract; 2005; 101(4):c174-9. PubMed ID: 16103722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients].
    Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F
    Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable effects of L-carnitine treatment on hypertriglyceridemia in hemodialysis patients: decisive role of low levels of high-density lipoprotein-cholesterol.
    Vacha GM; Giorcelli G; Siliprandi N; Corsi M
    Am J Clin Nutr; 1983 Oct; 38(4):532-40. PubMed ID: 6624695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment.
    Albertazzi A; Capelli P; Di Paolo B; Pola P; Tondi P; Vaccario O
    Proc Eur Dial Transplant Assoc; 1983; 19():302-7. PubMed ID: 6878245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects.
    Golper TA; Wolfson M; Ahmad S; Hirschberg R; Kurtin P; Katz LA; Nicora R; Ashbrook D; Kopple JD
    Kidney Int; 1990 Nov; 38(5):904-11. PubMed ID: 2266674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial.
    Bonomini M; Di Liberato L; Del Rosso G; Stingone A; Marinangeli G; Consoli A; Bertoli S; De Vecchi A; Bosi E; Russo R; Corciulo R; Gesualdo L; Giorgino F; Cerasoli P; Di Castelnuovo A; Monaco MP; Shockley T; Rossi C; Arduini A
    Am J Kidney Dis; 2013 Nov; 62(5):929-38. PubMed ID: 23725973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphometric evidence of the trophic effect of L-carnitine on human skeletal muscle.
    Spagnoli LG; Palmieri G; Mauriello A; Vacha GM; D'Iddio S; Giorcelli G; Corsi M
    Nephron; 1990; 55(1):16-23. PubMed ID: 2352575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of L-carnitine on arrhythmias during hemodialysis.
    Suzuki Y; Narita M; Yamazaki N
    Jpn Heart J; 1982 May; 23(3):349-59. PubMed ID: 6178854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis.
    Guarnieri GF; Ranieri F; Toigo G; Vasile A; Ciman M; Rizzoli V; Moracchiello M; Campanacci L
    Am J Clin Nutr; 1980 Jul; 33(7):1489-92. PubMed ID: 7395772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary L-carnitine deficiency in chronic hemodialysis patients].
    Achenbach H; Würzberger G; Seim H; Löster H; Strauss B
    Z Gesamte Inn Med; 1989 Jan; 44(1):18-22. PubMed ID: 2711712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis.
    Weschler A; Aviram M; Levin M; Better OS; Brook JG
    Nephron; 1984; 38(2):120-4. PubMed ID: 6472539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine status, plasma lipid profiles, and exercise capacity of dialysis patients: effects of a submaximal exercise program.
    Lennon DL; Shrago E; Madden M; Nagle F; Hanson P; Zimmerman S
    Metabolism; 1986 Aug; 35(8):728-35. PubMed ID: 3736413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy.
    Bertoli M; Battistella PA; Vergani L; Naso A; Gasparotto ML; Romagnoli GF; Angelini C
    Am J Clin Nutr; 1981 Aug; 34(8):1496-500. PubMed ID: 7270472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
    Böhles H; Michalk D; von Wendt-Göknur E
    Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
    Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F
    Atherosclerosis; 2006 Oct; 188(2):455-61. PubMed ID: 16384561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.